Live Chat ×
Skip to main content

ONS Symposium 2018 - The Spectrum of Bone Marrow Failure Diseases: Emerging Therapies and Precision Medicine Are Transforming Treatment

Release Date: August 1, 2018

Expiration Date:
July 31, 2019

Estimated Time of Completion: 1.5 hours

This symposium was recorded at the ONS 43rd Annual Congress in Washington, DC on May 17, 2018. The program focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management and care coordination. Case studies are used to illustrate treatment decision-making and therapeutic challenges.

Learning Outcomes
  1. Explain the role of genetic testing and precision medicine in diagnosing and treating bone marrow failure diseases;
  2. Identify emerging treatment options for patients with MDS, AML, MDS/MPN overlap and other bone marrow failure diseases;
  3. Analyze the nurse's role in managing treatment for bone marrow failure diseases based on clinical presentations, comorbidities and diagnostic workups;
  4. Discuss the nurse's role in collaboration with other disciplines in addressing quality of life issues and providing patient education to improve outcomes.
Nancy Corbitt, BSN, RN, OCN, CRNI , University of Maryland Greenebaum Cancer Center, Baltimore, MD

  • Katherine Edmonds, MSN, ANRP-C, Dana-Farber Cancer Institute, Boston, MA
  • Lisa Barbarotta, MSN, APRN-BC, AOCNS, Smilow Cancer Hospital, Yale Medical Center, New Haven, CT
  • Kelly Fields Owens , LMSW, Vanderbilt University Medical Center, Nashville, TN

This activity is jointly provided by Medical Learning Institute, Inc. and the Aplastic Anemia and MDS International Foundation.

Commercial Support Acknowledgement
This activity is supported by an educational grant from Celgene Corporation.

Target Audience
This activity was developed for nurses and nurse practitioners who are involved in the treatment or management of patients with bone marrow failure disease.

Nursing Education Purpose Statement
The purpose of this activity is to improve the knowledge and competence of nurses concerning the treatment or management of patients with bone marrow failure disease.

Registered Nurse Designation 
Medical Learning Institute, Inc.
Provider approved by California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hours.

Nurse Practitioner Credit Designation 
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 1.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18063240. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Social Worker Credit Designation
This program is Approved by the National Association of Social Workers (Approval # 886609639-5881) for 1.5 continuing education contact hours.

Method of Participation
There are no fees for participating in and receiving credit for this activity. Participants must:
  1. read the learning outcomes and faculty disclosures
  2. watch and study the educational activity
  3. complete the appropriate post-test (one is for nurse/NP credits and one is for social worker credits), a passing score of 70% or better is required for nurses and nurse practitioners and 80% or better for social workers
  4. complete the evaluation form
  5. access the certificate of completion and print/save for your records
For more free nursing education programs from AAMDSIF, please visit the links below:
CE accredited free programs